Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A new talk therapy aims to tackle both insomnia and PTSD in veterans

NCT ID NCT05194930

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial compares a novel behavioral treatment called ABC-I (Acceptance and the Behavioral Changes to treat Insomnia) with standard cognitive-behavioral therapy for insomnia (CBT-I) in veterans who have both PTSD and insomnia. ABC-I combines sleep-focused behavioral techniques with acceptance and commitment therapy to improve adherence. Researchers will measure changes in PTSD symptoms, insomnia severity, and sleep quality over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acceptance and the Behavioral Changes to treat Insomnia (ABC-I) therapy
What this could lead to
If ABC-I works better than standard therapy, it could offer veterans with PTSD a more effective, adherence-friendly option for treating both insomnia and PTSD symptoms.
What could go wrong
This is a relatively early-stage comparison with 200 participants, so results may not generalize. The therapy is behavioral and requires active participation, which may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2022

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * community-dwelling Veterans aged 18 years and older, * received care from VAGLAHS in the prior year, * live within a 50-mile radius of the research offices at the VA Sepulveda Ambulatory Care Center, * have symptoms of PTSD, * have symptoms of insomnia. Exclusion Criteria: * current pregnancy or has a child less than 6 months of age (men and women), * active substance users or in recovery with less than 90 days of sobriety, * too ill to engage in the study procedures, * unable to self-consent to participate, * unstable housing (since we may not be able to retrieve costly and difficult to replace monitoring equipment), * severe, untreated sleep disordered breathing (AHI\>15 with excessive daytime sleepiness, or AHI\>30), * restless legs syndrome that accounts for the sleep disturbances reported, * a circadian rhythm sleep disorder that accounts for the sleep disturbances reported (including shift work sleep disorder), * unstable medical or psychiatric disorders (which is a contraindication for behavioral treatment of insomnia); * remission of insomnia symptoms prior to randomization; * current participation in prolonged exposure therapy for PTSD.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insomnia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Miami VA Healthcare System, Miami, FL

    ACTIVE_NOT_RECRUITING

    Miami, Florida, 33125, United States

  • VA Greater Los Angeles Healthcare System, Sepulveda, CA

    RECRUITING

    Sepulveda, California, 91343, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.